Molecular Classification
Glycoprotein, Cell surface antigen
Other Names
CAMPATH-1 antigen, HE5 antigen
Disease Roles
B-cell malignanciesChronic Lymphocytic LeukemiaAutoimmune diseases

CD52 Antigen Overview

CD52, also known as CAMPATH-1 antigen, is a small, heavily glycosylated cell surface glycoprotein expressed on mature lymphocytes, monocytes, macrophages, eosinophils, dendritic cells, epithelial cells of the male reproductive tract, and spermatozoa. Its precise physiological role remains unclear, but proposed functions include antiadhesion, regulation of T-cell activation, and costimulation for regulatory T-cells. It is a therapeutic target for alemtuzumab, an anti-CD52 monoclonal antibody used in the treatment of B-cell malignancies, autoimmune diseases like multiple sclerosis, and potentially systemic mastocytosis.

Mechanism of Action

Alemtuzumab induces complement-dependent cytotoxicity and antibody-dependent cellular cytotoxicity, leading to lymphocyte depletion.

Biological Functions

Antiadhesion
Regulation of T-cell activation
Costimulation for regulatory T-cells
Lymphocyte transendothelial migration
Fertilization processes

Disease Associations

B-cell malignancies
Chronic Lymphocytic Leukemia
Autoimmune diseases
Multiple Sclerosis
Systemic Mastocytosis

Safety Considerations

No safety concerns listed

Interacting Drugs

Alemtuzumab (CAMPATH)